Compare CSL & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSL | ZBH |
|---|---|---|
| Founded | 1917 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.3B | 16.0B |
| IPO Year | 1994 | 2001 |
| Metric | CSL | ZBH |
|---|---|---|
| Price | $387.53 | $96.51 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 21 |
| Target Price | ★ $401.67 | $101.00 |
| AVG Volume (30 Days) | 514.6K | ★ 2.3M |
| Earning Date | 04-23-2026 | 04-28-2026 |
| Dividend Yield | ★ 1.27% | 1.20% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 9.37 | 2.25 |
| Revenue | $5,003,600,000.00 | ★ $8,231,500,000.00 |
| Revenue This Year | $2.59 | $4.96 |
| Revenue Next Year | $4.50 | $3.76 |
| P/E Ratio | ★ $40.86 | $43.20 |
| Revenue Growth | ★ 9.08 | 7.20 |
| 52 Week Low | $293.43 | $79.12 |
| 52 Week High | $432.91 | $108.29 |
| Indicator | CSL | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 61.97 | 60.11 |
| Support Level | $324.65 | $85.95 |
| Resistance Level | $396.12 | $102.59 |
| Average True Range (ATR) | 12.85 | 2.68 |
| MACD | 5.84 | 0.46 |
| Stochastic Oscillator | 86.01 | 66.90 |
Carlisle Companies Inc is a holding company that manufactures and sells single-ply roofing products and warranted systems and accessories for the commercial building industry. It operates through two segments: Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The majority of revenue comes from Carlisle Construction Materials, and more than half of total revenue is earned in the United States. Carlisle Construction Materials produces premium single-ply roofing products and warranted roof systems, including EPDM, TPO, PVC membrane, and polyiso insulation. Carlisle Weatherproofing Technologies produces building envelope solutions, including waterproofing, moisture protection products, air/vapor barriers, and spray polyurethane foam systems.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.